Abacavir/ dolutegravir/ lamivudine ViiV Healthcare Company 6/7/2023 Abatacept BMS 2/14/2017
  Acetaminophen Mallinckrodt 7/11/2016 Afatinib  Boehringer Ingelheim Pharmaceuticals, Inc. 3/8/2022 Aflibercept Regeneron Pharmaceuticals 10/18/2022 Albuterol GlaxoSmithKline 8/27/2008 Alfuzosin Sanofi Aventis 9/7/2010 Aliskiren Noden Pharma DAC 10/3/2017 Almotriptan Johnson & Johnson Pharmaceutical Research & Development 1/13/2009 Amphetamine Shire 8/18/2019 Anastrozole AstraZeneca 11/14/2007 Apremilast Amgen Inc. 4/22/2024 Aripiprazole Otsuka 11/14/2007 Asenapine Forest Labs 3/3/2015 Atazanavir  BMS 6/23/2015 Atezolizumab Genentech 9/22/2020 Axitinib Pfizer, Inc. 7/2/2024 Azelastine/Fluticasone and Azelastine Meda Pharmaceuticals 3/23/2015 Bendamustine Cephalon 5/24/2012 Bezlotoxumab Merck Sharpe and Dohme 5/12/2023 Bicalutamide AstraZeneca 9/19/2008 Bivalirudin The Medicines Company 6/17/2009 Blinatumomab Amgen 6/13/2023 Bosutinib PF Prism, C.V. 9/7/ 2023  Bortezomib  Millennium Pharmaceuticals 8/14/2015 Brentuximab vedotin Seagen, Inc. 11/18/2022 Brexpiprazole Otsuka Pharmaceutical Development & Commercialization 5/2/2024 Budesonide/Formoterol AstraZeneca
  1/25/2017
  Cabazitaxel Sanofi Aventis
  5/18/2017 Calcipotriene/Betamethasone Leo Pharma 7/15/2019 Canagliflozin Janssen Pharmaceuticals, Inc. 12/9/2024 Candesartan AstraZeneca Pharmaceuticals LP 7/20/2009 Capecitabine Hoffman-La Roche, Inc. 8/28/2013 Caspofungin Merck & Co., Inc. 4/15/2008 Cetirizine Nicox Ophthalmics  8/29/16  Clopidogrel Sanofi Aventis 1/20/2011 Cobimetinib Genentech, Inc. 7/19/2022 Colesevelam Daiichi Sankyo Pharma 2/17/2009 Crisaborole Pfizer 2/21/2020 Cysteamine Horizon 12/12/2017 Dabigatran Boehringer Ingelheim Pharmaceuticals, Inc. 2/12/2021 Dabrafenib Novartis  2/9/2023 Dapagliflozin AstraZeneca AB 5/30/2024 Darunavir Tibotec 6/7/2011 Deutetrabenazine  Teva Branded Pharmaceutical Products 5/5/2021

/

Dexmedetomidine Hospira 3/12/2013 Difluprednate Alcon 3/21/2013 Docetaxel Sanofi Aventis 3/17/2010 Dulaglutide Eli Lilly and Company October 4, 2022 Duloxetine Eli Lilly 7/2/2012 Efavirenz BMS 1/29/2013 Eltrombopag  Novartis 8/14/2015 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead Sciences, Incorporated 9/13/2021 Empagliflozin/Empagliflozin and Metformin hydrochloride Boehringer Ingelheim Pharmaceuticals 6/9/2023 Entecavir BMS 12/5/2013 Eplerenone Pfizer 10/24/2007 Eribulin Mesylate Eisai, Inc. 8/9/2022 Erlotinib OSI Pharmaceuticals 3/18/2015 Esomeprazole AstraZeneca LP 5/1/2009 Eszopiclone Sunovion 6/29/2012 Etravirine  Janssen 6/21/2018 Everolimus Novartis 7/10/2012 Exenatide AstraZeneca 4/1/2021 Ezetimibe Schering Corporation 2/14/2008 Famciclovir Novartis 9/21/2009 Fenfluramine hydrochloride Zogenix, Inc  3/23/2022 Ferric Oxyhydroxide Vifor Fresenius Medical Care Renal Pharma France 6/1/2021 Fesoterodine Pfizer 6/3/2021 Fidaxomicin Cubist 12/13/2019 Finafloxacin Alcon 8/25/2014

Fingolimod  

 

Novartis 4/16/2018
  Fluticasone & Fluticasone/Salmeterol  Teva Pharmaceutical Industries Ltd. 6/10/2021 Fluticasone furoate vilanterol trifenatate GlaxoSmithKline 4/26/2023 Fosamprenavir ViiV Healthcare 1/10/2012 Fosaprepitant Merck  3/23/2018 Fulvestrant AstraZeneca 2/1/2011 Gatifloxacin Allergan 5/19/2009 Glecaprevir/Pibrentasvir AbbVie, Inc. 5/18/2021 Guanfacine Shire 10/17/2014

Halobetasol

Mayne Pharma LLC 5/21/2021 Ibrutinib  Pharmacyclics  8/8/2022 Ipilimumab BMS 7/20/17 Isavuconazonium sulfate Astellas Pharma US Inc. 11/29/2023 Ixabepilone  BMS 4/5/2011 Ivabradine   
  Amgen 3/30/2019 Lanadelumab Takeda Pharmaceuticals U.S.A., Inc. 12/20/2022 Lansoprazole Tap Pharmaceutical Products, Inc. 7/15/2008 Lenvatinib Mesylate Eisai Inc. 4/1/2024 Levetiracetam UCB, Inc. 6/3/2008 Levocetirizine UCB, Inc. 8/25/2009 Linagliptin/Linagliptin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals 6/9/2023 Liraglutide  Novo Nordisk 5/1/2019 Lisdexamfetamine  Takeda Pharmaceuticals USA, Inc.
  7/27/2021 Loteprednol/Tobramycin Bausch & Lomb 12/28/2010 Lopinavir/Ritonavir Abbott Laboratories 3/7/2008 Lumacaftor/Ivacaftor Vertex Pharmaceuticals Inc. 12/11/2024 Lurasidone Sunovion 12/20/2016 Lutetium Lu 177 dotatate Advanced Accelerator Applications 4/19/2024 Maraviroc ViiV Healthcare Co 7/29/2020 Memantine Forest Labs 6/16/2014 Methylphenidate
  Rhodes Pharmaceuticals 3/15/2019 Micafungin Astellas 11/14/2019 Mirabegron Astellas Pharma Global Development, Inc. 3/1/2021 Mometasone/formoterol Merck 6/24/2019 Nilotinib Novartis 3/20/2018 Nintedanib Boehringer Ingelheim Pharmaceuticals 10/6/2023 Nitric Oxide INO Therapeutics 11/2/2010 Nivolumab
    2/2/2023 Olmesartan Daiichi Sankyo 10/7/2009 Olopatadine Alcon Research, Ltd. 8/12/2009 Olopatadine Alcon Research, Ltd. 12/16/2014 Paclitaxel Abraxis 11/8/2019 Paliperidone Ortho-McNeil-Janssen Pharmaceuticals, Inc. 1/5/2011 Palonosetron Helsinn 4/10/2014 Pantoprazole Wyeth Pharmaceuticals, Inc. 2/17/2009 Pemetrexed Eli Lilly 12/3/2010 Phenylephrine/Ketorolac Omeros 12/6/2017 Pitavastatin   
  Kowa Research Institute] 3/30/2019 Pomalidomide Celgene Corporation 10/16/2020 Prasugrel   Eli Lilly 5/23/16 Quetiapine AstraZeneca Pharmaceuticals LP 1/23/2009 Rabeprazole Eisai 12/4/2012 Raltegravir Merck 8/14/2017 Remdesivir Gilead Sciences, Inc. January 23, 2024 Rilpivirine Janssen Products, LP. 1/18/2024 Risedronate Procter & Gamble Pharmaceuticals, Inc. 4/24/2009 Rivaroxaban  Janssen Pharmaceuticals, Inc. 11/23/2021 Rizatriptan Merck 9/20/2011 Rocuronium Organon, Inc. 4/3/2008 Rosuvastatin AstraZeneca Pharmaceuticals LP 7/7/2009 Rufinamide Eisai 1/13/2015 Ruxolitinib Incyte Corporation 12/1/2022 Sacubitril/Valsartan

Novartis

9/26/2019 Sapropterin BioMarin 3/13/2014 Saquinavir Hoffman-La Roche, Inc. 10/26/2010 Sildenafil Pfizer 2/9/2012 Sitagliptin Merck Sharp & Dohme Corp. 10/30/2020 Sofosbuvir Gilead Sciences, Inc. 7/23/2019 Sofosbuvir/Ledipasvir Gilead Sciences, Inc. 7/23/2019 Sofosbuvir/Velpatasvir
  Gilead Sciences, Inc. 5/13/2021 Solifenacin Astellas 7/20/2017 Sugammadex Merck, Sharp & Dohme LLC (Merck) 12/9/2024 Sumatriptan/Naproxen GlaxoSmithKline/Pernix 4/16/2015 Tadalafil   Eli Lilly  11/16/2017  Tamsulosin Boehringer Ingelheim 9/17/2009 Tapentadol Collegium Pharmaceutical Inc. June 11, 2024 Tavaborole Anacor 7/18/2018 Tbo-filgrastim Sicor
  7/18/2018 Technetium Tc99 sestamibi BMS 1/11/2008 Teduglutide  Shire – NPS Pharmaceuticals 
  3/7/2019 Temsirolimus Pfizer 2/28/2012 Tenofovir Gilead Sciences, Inc. 9/6/2011 Tenofovir
  Gilead Sciences, Inc. 11/15/2018

 

Teriflunomide Sanofi Aventis 3/31/2021 Ticagrelor AstraZeneca 4/8/2022 Tiotropium Boehringer Ingelheim Pharmaceuticals, Inc. 12/14/16 Tipranavir Boehringer Ingelheim Pharmaceuticals, Inc. 3/7/2008 Tocilizumab Genentech/Hoffmann-La Roche
  7/18/2018 Tofacitinib NEW Pfizer, Inc 02/19/2025 Topiramate Ortho-McNeil-Janssen Pharmaceuticals, Inc. 7/24/2008 Trabectedin Janssen 6/12/2018 Trametinib Novartis 2/9/2023 Valacyclovir GlaxoSmithKline 2/28/2008 Valganciclovir Hoffman-La Roche Inc. 7/24/2008 Valproate   Abbott 12/14/2007 Varenicline
  Pfizer 11/15/2018 Vigabatrin Lundbeck 10/3/2013 Vilazodone Allergan 1/21/2020 Vortioxetine Takeda Pharmaceuticals USA Inc. 8/21/2023 Zoledronic acid Novartis 12/21/2007

Source

Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting

"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.

Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.